Cart
sales@molnova.com
7,2,4-Trihydroxy-5-methoxy-3-phenylcoumarin
CAS No. 1092952-62-9
7,2,4-Trihydroxy-5-methoxy-3-phenylcoumarin( —— )
Catalog No. M31359 CAS No. 1092952-62-9
7,2',4'-Trihydroxy-5-methoxy-3-arylcoumarin shows activity in inhibiting prostate specific antigen (PSA) secreted from androgen dependent prostate cancer cell line, LNCaP cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 691 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
Biological Information
-
Product Name7,2,4-Trihydroxy-5-methoxy-3-phenylcoumarin
-
NoteResearch use only, not for human use.
-
Brief Description7,2',4'-Trihydroxy-5-methoxy-3-arylcoumarin shows activity in inhibiting prostate specific antigen (PSA) secreted from androgen dependent prostate cancer cell line, LNCaP cells.
-
Description7,2',4'-Trihydroxy-5-methoxy-3-arylcoumarin shows activity in inhibiting prostate specific antigen (PSA) secreted from androgen dependent prostate cancer cell line, LNCaP cells.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1092952-62-9
-
Formula Weight300.3
-
Molecular FormulaC16H12O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Varespladib methyl
Varespladib methyl, a bioavailable prodrug of Varespladib, is a selective group II secretory phospholipase A2 inhibitor.
-
(R)-HTS-3
(R)-HTS-3, a lysophosphatidylcholinacyltransferase 3 (LPCAT3) inhibitor, remodels polyunsaturated phospholipid content in human cells and reduces RSL3-induced ferroptosis in cancer cells.
-
Z-Phe-Ala-NH2
Heterocyclic Organic Compound
